No Data
No Data
Qianhai Health's Loss Shrinks in 2023
Qianhai Health Holdings (HKG:0911) saw a decline in attributable loss for the year ended Dec. 31, 2023, to HK$52.7 million from HK$233.7 million in 2022, according to a filing with the Hong Kong bours
Qianhai Health (00911) announces 2023 annual results. Shareholders' loss of HK$52.755 million during the year narrowed by 77.45% year-on-year
Qianhai Health (00911) announced its annual results for the year ended December 31, 2023. The group made profits during the period...
前海健康:截至二零二三年十二月三十一日止年度的 年度業績公告
Qianhai Health [00911] now reports HK$0.021, a decrease of 12.50%
As of 09:49, Qianhai Health [00911] reported HK$0.021, down HK$0.003 or 12.50% from yesterday's closing price. Today's high price was HK$0.021 and the lowest price was HK$0.021. Based on yesterday's closing price, the 10-day average price was HK$0.03, and the 50-day average price was HK$0.03. The current price-earnings ratio was -0.17 times, and the 14-day strong and weak index was reported at 0.00.
Qianhai Health (00911.HK) expects annual losses to be reduced by about 77%
On February 8, GLONGHUI | Qianhai Health (00911.HK) announced that the company expects to record losses of about 77% for the year ended December 31, 2023, and recorded a loss of about HK$233.7 million compared to the previous year. Despite a decrease in the average sales price (lower than inventory price) and sales volume of electronic components sold by the Group this year, which led to a decrease in the Group's total revenue and recorded gross loss (gross profit recorded in the previous year), the Group expects to record a decrease in losses this year. This improvement was mainly due to a slight rebound in the average semiconductor sales price in the last quarter of this year, resulting in no confirmed inventory or loss contracts this year
QIANHAI HEALTH: INSIDE INFORMATION - EXPECTED DECREASE IN LOSS
No Data